Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05126082 · ClinicalTrials.gov registry record · NA
Pediatric Blood Pressure Clinical Decision Support Tool (PedsBP CDS)
A NA study of Hypertension, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 41,054
- Enrollment target
- 1
- Study location
NCT05126082: Completed NA study of Hypertension, sponsored by HealthPartners Institute.
NCT05126082 is a NA study of Hypertension that has completed, run by HealthPartners Institute. The registered enrollment target is 41,054 participants, above the 3,420-participant average among 470 other Hypertension trials with a reported enrollment target (1100% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05126082, a NA study of Hypertension, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 41,054 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the PedsBP CDS research project is to adapt a previously tested web-based clinical decision support tool that appropriately identifies high blood pressure in youth for use in a primarily rural health system and compare approaches to CDS implementation in 45 primary care clinics treating children in 3 upper Midwest states. This project will advance implementation science and address a critical need for youth at risk for cardiovascular disease and with limited access to pediatric subspecialty care.
Primary Outcome
Number of participants with blood pressure re-measurement at the index primary care encounter, among those with a first elevated blood pressure at the index primary care encounter.
Conditions Studied
Interventions
- BEHAVIORAL PedsBP CDS
Study Locations (1)
Minnesota
- Essentia Health - Duluth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41,054 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT05126082 record still lists
NCT05126082 is an interventional study that assigns participants to a tested intervention. Its 41,054 participants enrollment target places it among the larger protocols in the corpus, above the 3,420-participant average among 470 other Hypertension trials with a reported enrollment target (1100% higher).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which PedsBP CDS is the first listed.
NCT05126082 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05126082 about?
NCT05126082 is a clinical study titled "Pediatric Blood Pressure Clinical Decision Support Tool (PedsBP CDS)". The goal of the PedsBP CDS research project is to adapt a previously tested web-based clinical decision support tool that appropriately identifies high blood pressure in youth for use in a primarily rural health system and compare approaches to CDS implementation in 45 primary care clinics treating ...
What is the current status of trial NCT05126082?
This trial is currently completed. It is a NA study. The enrollment target is 41,054 participants. The study started on 2022-08-01. Estimated completion is 2025-07-31.
What conditions does trial NCT05126082 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT05126082?
The interventions under investigation include: PedsBP CDS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05126082?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05126082 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05126082's enrollment target sits among peer trials
41,054 7th of 470 higher than 464 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI